HCWB HCW BIOLOGICS INC Company Mergers 8-K Filing 2024 - License Agreement HCW Biologics Inc. has signed a worldwide License Agreement with WY Biotech Co., Ltd. for a preclinical molecule, receiving an upfront fee of $7 million, with additional payments tied to clinical development milestones and potential royalties upon commercialization.Get access to all SEC 8-K filings of the HCW BIOLOGICS INC